Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ohashi

Showing results (641-650 of 703) with videos related to

Pageof 71
Sort By:
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 1, 1997
[The physical, mental and social impacts of telling prostate cancer patients the true diagnosis]M Niimi, H Akaza, H Takeshima, et al.
The Tohoku Journal of Experimental Medicine|May 20, 1998
Detection of the PGP9.5 and tyrosine hydroxylase mRNAs for minimal residual neuroblastoma cells in bone marrow and peripheral bloodT Y Yanagisawa, Y Sasahara, H Fujie, et al.
Clinical and Experimental Immunology|April 17, 2004
High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic backgroundM Okamoto, M Takagi, M Kutsuna, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2003
A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group)M Shiraki, M Fukunaga, K Kushida, et al.
Molecules and Cells|March 27, 2001
Molecular cloning and cultivar specific expression of MAP kinases from Capsicum annuumH J Shin, D E Lee, D H Shin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 3, 2002
A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trialM Fukunaga, K Kushida, H Kishimoto, et al.
Anticancer Research|April 27, 1999
Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study GroupK Fujiwara, I Kohno, K Tanaka, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 18, 2002
Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim reportH Sone, A Katagiri, S Ishibashi, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 9, 1998
Current progress in the development of a totally implantable Gyro centrifugal artificial heartY Takami, G Ohtsuka, J Mueller, et al.
Prostate Cancer and Prostatic Diseases|January 3, 2007
Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patientsM Usami, H Akaza, Y Arai, et al.
Pageof 71

Showing results (641-650 of 703) with videos related to

Sort By:
Pageof 71
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 1, 1997
[The physical, mental and social impacts of telling prostate cancer patients the true diagnosis]M Niimi, H Akaza, H Takeshima, et al.
The Tohoku Journal of Experimental Medicine|May 20, 1998
Detection of the PGP9.5 and tyrosine hydroxylase mRNAs for minimal residual neuroblastoma cells in bone marrow and peripheral bloodT Y Yanagisawa, Y Sasahara, H Fujie, et al.
Clinical and Experimental Immunology|April 17, 2004
High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic backgroundM Okamoto, M Takagi, M Kutsuna, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2003
A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group)M Shiraki, M Fukunaga, K Kushida, et al.
Molecules and Cells|March 27, 2001
Molecular cloning and cultivar specific expression of MAP kinases from Capsicum annuumH J Shin, D E Lee, D H Shin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 3, 2002
A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trialM Fukunaga, K Kushida, H Kishimoto, et al.
Anticancer Research|April 27, 1999
Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study GroupK Fujiwara, I Kohno, K Tanaka, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 18, 2002
Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim reportH Sone, A Katagiri, S Ishibashi, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 9, 1998
Current progress in the development of a totally implantable Gyro centrifugal artificial heartY Takami, G Ohtsuka, J Mueller, et al.
Prostate Cancer and Prostatic Diseases|January 3, 2007
Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patientsM Usami, H Akaza, Y Arai, et al.
Pageof 71